Previous Article | Next Article ![]()
J. Virol., Nov 1995, 6925-6931, Vol 69, No. 11
M Heinkelein, S Sopper and C Jassoy
Individuals infected with the human immunodeficiency virus (HIV) experience
a marked loss of CD4+ T lymphocytes, leading to fatal immunodeficiency. The
mechanisms causing the depletion of these cells are not yet understood. In
this study, we observed that CD4+ T lymphocytes from HIV type 1
(HIV-1)-infected and uninfected individuals rapidly lysed B lymphoblasts
expressing the HIV-1 envelope glycoprotein on the cell surface and Jurkat
cells expressing the complete virus. Contact of uninfected CD4+ T cells
with envelope glycoprotein- expressing cells also resulted in the lysis of
the uninfected CD4+ T cells. Cytolysis did not require priming or in vitro
stimulation of the CD4+ T cells and was not restricted by major
histocompatibility complex molecules. Cytotoxicity was inhibited by soluble
CD4 and anti-CD4 monoclonal antibodies that block binding of CD4 to gp120.
In addition, neutralizing anti-CD4 and anti-gp120 monoclonal antibodies
which block postbinding membrane fusion events and syncytium formation also
inhibited cell lysis, suggesting that identical mechanisms in HIV- infected
cultures underlie cell-cell fusion and the cytolysis observed. However,
cytotoxicity was not always accompanied by the formation of visible
syncytia. Rapid cell lysis after contact of uninfected and HIV- 1-infected
CD4+ T cells may explain CD4+ T-cell depletion in the absence of detectable
syncytia in infected individuals. Moreover, because of its vigor, lysis of
envelope-expressing targets by contact with unprimed CD4+ T lymphocytes may
at first glance resemble antigen- specific immune responses and should be
excluded when cytotoxic T- lymphocyte responses in infected individuals and
vaccinees are evaluated.
Copyright © 1995, American Society for Microbiology
Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells
Institute for Virology and Immunobiology, Wurzburg University, Germany.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|